Industry news

Annual venture investment dollars rise 7% and exceed 2012 totals, according to the Moneytree Report

National Venture Capital Assocoation - USA

Putin wants policy makers to allow for Russian science’s competitive advantages

Marchmont Innovation News

President Vladimir Putin of Russia wants the Russian Government to consider changing the very principle of funding scientific research. His  decree was published on January 15 on the Kremlin website among other presidential statements made in the wake of the December 20, 2013 meeting with members of the Presidential Council for Science and Education. 

Russia’s nanotech sector boosted production by 50 times in 3 years, Chubais said

Marchmont Innovation News

In 2013, Russia’s nanotech companies generated about $1.5bn worth of products, according to preliminary results voiced by Anatoly Chubais. The Rusnano president made this estimate,  reported  by Russian business daily RBC, at a most recent meeting with Prime Minister Dmitry Medvedev of Russia. 
 

Healthcare Industry: Russia Over-the-counter (OTC) Drugs Industry Research Report

CSO

The Russian pharmaceutical industry has continued to evolve through government funding and international cooperation. The domestic industry will develop further in order to decrease the country’s dependency on foreign medicines. Economic reforms in the country are still underway along with legal, tax and regulatory developments with the market requirements. The future potential of the Russian economy is largely subject to such reforms and can alter the efficiency of the government’s economic, financial and monetary policy. The vigorous development of the Russian OTC drugs market has gained attraction among the western companies as well as for investors. The Russian OTC drugs market has experienced an average annual growth rate of 10.3% over the period 2006-2012.

The Next Emerging Markets After BRIC

Life Science Leader

According to the Business Perspectives on Emerging Markets 2012-2017 Report by Global Intelligence Alliance (GIA), Brazil, Russia, India and China (BRIC) will retain their leading positions as the worlds’ top emerging markets for 2012-2017. In a ranking of the top 30 emerging markets international companies plan to target in 2012-2017, most of the non-BRIC emerging markets are in Asia or Latin America, with Indonesia, South Africa, Vietnam, Mexico, Turkey and Argentina ranking highest amongst secondary emerging markets.

Drugmakers Should Disclose More Trial Data: U.K. Report

Kristen Hallam, Bloomberg Technology

Doctors and researchers should have access to information from clinical trials related to all uses of medicines on the market, U.K. lawmakers said in a report to influence the government’s purchasing decisions.

Stronger exit market, more investment and improved economy among the 2014 predictions from venture capitalists & CEOs

National Venture Capital Assocoation

Venture capitalists (VCs) and Chief Executive Officers of venture-backed companies (CEO s) are showing a mix of greater optimism, confidence and measured concern for the venture ecosystem in 2014 according to the results from this year’s Venture View predictions survey. The survey was conducted by the National Venture Capital Association (NVCA) and Dow Jones’ DJX VentureSource. 

Silicon Valley just had its most lucrative quarter in five years

Alice Truong, Fast Feed

After a slow start to the year, the number of deals in Silicon Valley has risen to 267 in the third quarter totaling $2.85 billion, up from 251 deals and $2.6 billion invested the same period last year.

Emerging Markets And Your Global Regulatory Strategy

Life Science Leader

In the early 1980s, talking about the worldwide pharmaceutical market really meant the U.S., Japan, and Europe, which comprised the bulk of total sales, with the rest of the world (ROW) thrown in somewhat as an afterthought. Today, ROW is a term of the past, and with increasing speed, the concepts have changed from “developing” to “emerging” and now to “growth” markets, with China already today having become a major market, the number two global pharmaceutical market. 

Nanotechnology Center T-Nano Opens in Moscow

Rusnano

Andrey Svinarenko and Vsevolod Opanasenko, respectively the CEO of the Fund for Infrastructure and Educational Programs and the general director of the company  T-Platforms , attended the official opening of  T-Nano  in Moscow. The nanotechnology center has a budget exceeding two billion rubles of which the Fund for Infrastructure and Educational Programs is cofinancing 1.2 billion rubles.